A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 35/12 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2718884
The invention provides a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a heat shock protein (hsp) gp96 polypeptide. The invention also provides a method of stimulating an immune response to a tumor by administering a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a gp96 polypeptide.
Cette invention concerne une cellule tumorale génétiquement modifiée pour exprimer un acide nucléique codant pour une forme sécrétée d'un polypeptide de la protéine de choc thermique (hsp) gp96. L'invention concerne également un procédé de stimulation d'une réponse immunitaire à une tumeur par administration d'une cellule tumorale génétiquement modifiée pour exprimer un acide nucléique codant pour une forme sécrétée d'un polypeptide de gp96.
Podack Eckhard R.
Rosenblatt Joseph R.
Borden Ladner Gervais Llp
University Of Miami
LandOfFree
Heat shock protein gp96 vaccination and methods of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heat shock protein gp96 vaccination and methods of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heat shock protein gp96 vaccination and methods of using same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1348189